Literature DB >> 17262042

Role of multiple site blood cultures to document the clearance of bacteremia in neonates.

S Sarkar1, I Bhagat, T E Wiswell, A R Spitzer.   

Abstract

OBJECTIVE: To evaluate the usefulness of two-site blood cultures for the documentation of bacterial clearance during initial treatment of culture proven neonatal sepsis. DESIGN/
METHODS: Clinical data were prospectively collected for 216 neonates who had blood cultures drawn for evaluation of possible sepsis. A positive diagnostic blood culture was followed by repeat blood cultures from two different peripheral sites after initiation of antimicrobial therapy.
RESULTS: Follow-up two-site cultures were drawn on 25 occasions at a median interval of 3 days after start of antimicrobial therapy for culture-proven sepsis in 15 neonates. On 12 occasions, follow-up blood cultures were both negative. On eight occasions, follow-up blood cultures grew the same organisms from both sites. However, follow-up two-site cultures on five occasions in four of the 15 infants grew organisms from one site but not the second site.
CONCLUSIONS: Two-site blood cultures seem necessary to document bacterial clearance in response to antimicrobial therapy for culture-proven sepsis, and may help determine the appropriate duration of antimicrobial therapy by reducing false-negative results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262042     DOI: 10.1038/sj.jp.7211636

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.

Authors:  Yanan Zhao; Steven Park; Barry N Kreiswirth; Christine C Ginocchio; Raphaël Veyret; Ali Laayoun; Alain Troesch; David S Perlin
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

2.  Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.

Authors:  Iris van Maldeghem; Charlotte M Nusman; Douwe H Visser
Journal:  BMC Immunol       Date:  2019-06-03       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.